e-learning
resources
Munich 2006
Sunday 03.09.2006
Pulmonary embolism and hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension
L. Webster, S. Archer, E. Michelakis (Edmonton, Canada)
Source:
Annual Congress 2006 - Pulmonary embolism and hypertension
Session:
Pulmonary embolism and hypertension
Session type:
E-Posters in free access
Number:
384
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Webster, S. Archer, E. Michelakis (Edmonton, Canada). A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension. Eur Respir J 2006; 28: Suppl. 50, 384
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Combined utility of brain natriuretic peptide and cardiac troponine I may improve rapid triage and risk stratification in patients with pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005
Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 1286-1293
Year: 2010
The diagnostic value of N-terminal pro-C-type natriuretic peptide in COPD patients with pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Novel biomarkers for risk stratification in pulmonary arterial hypertension
Source: ERJ Open Res 2015; 1: 00008-2015
Year: 2015
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pulmonary hypertension and renal insufficiency
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment
Source: Eur Respir J 2006; 28: Suppl. 50, 425s
Year: 2006
Patients with primary or thromboembolic pulmonary hypertension develop renal resistance to ANP and BNP
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
NT-proBNP variation in stable pulmonary arterial hypertension patients.
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension
Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020
Year: 2020
Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide
Source: Annual Congress 2007 - New insight into the pathophysiology of asthma
Year: 2007
Brain natriuretic peptides in patients with idiopathic pulmonary hypertension and chronic thromboembolic disease
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
Source: Eur Respir J 2010; 35: 95-104
Year: 2010
Risk stratification and medical therapy of pulmonary arterial hypertension
Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018
Year: 2019
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
Year: 2020
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept